Related Experiment Video

Updated: May 9, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Association between obesity and postoperative atrial fibrillation in patients undergoing cardiac operations: a

Adrian V Hernandez1, Roop Kaw, Vinay Pasupuleti

  • 1Postgraduate School, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru. adrianhernandezdiaz@gmail.com

The Annals of Thoracic Surgery
|August 13, 2013
PubMed

Keywords:
24ACEAFARBsBMIBSACABGCADCHFCICK-MBCOPDCPBTCVDDMECCEDIVSTEFESIVSTFEFFPHDLIABPICUIVLDLLVEFM-HMIMOOSEMantel-HaenszelMeta-analysis of Observational Studies in EpidemiologyNAORPCPOAFPRISMAPUFAPVDPreferred Reporting Items for Systematic Reviews and Meta-AnalysesRBCRCRFSDSESPBangiotensin II receptor blockersangiotensin-converting enzymeatrial fibrillationbody mass indexbody surface areacardiopulmonary bypass timecerebrovascular diseasechronic obstructive pulmonary diseaseconfidence intervalcongestive heart failurecoronary artery bypass graftingcoronary artery diseasecreatinine kinase-myocardial banddiabetes mellitusejection fractionend-diastolic intraventricular septum thicknessend-systolic intraventricular septum thicknessextracorporeal circulationfinite elementfresh frozen plasmahigh density lipoproteinintensive care unitintraaortic balloon pumpinverse varianceleft ventricular ejection fractionlow density lipoproteinmyocardial infarctionnot availableodds ratioperipheral vascular diseasepolyunsaturated fatty acidpostoperative atrial fibrillationprospective cohortred blood cellsrespiratory failureretrospective cohortstandard deviationstandard errorsupraventricular premature beats

More Related Videos

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion05:30

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...